A PYMNTS Company

European Commission ends probe of AstraZeneca and Nycomed

 |  March 2, 2012

The European Commission has ended its investigation of AstraZeneca and Nycomed. The Commission had launched unannounced investigations at premises of several pharmaceutical companies on November 30, 2010. Its probe centered around possible individual or joint plans to delay generics, in violation of Articles 101 and 102 of the TFEU.

Source: EC Press Release


Related content: Whistling Past the Graveyard: The Problem with the Per Se Legality Treatment of Pay-For-Delay Settlements (Michael Kades, U.S. Federal Trade Commission)